•
Jun 30, 2018

Denali Therapeutics Q2 2018 Earnings Report

Total Revenue
$1.65M
EPS
-$0.59
Previous year: -$0.324
+81.9%
Gross Profit
-$50.5M
Previous year: -$19M
+165.7%
Cash and Equivalents
$33.1M
Free Cash Flow
-$42.4M
Total Assets
$572M

Denali Therapeutics

Denali Therapeutics